Renal Cell Carcinoma: Characteristics of Patients, Treatment, and Disease Progression Based on Real-World Data From a Cancer Center in Medellín, Colombia.

Cureus · 2026 · PMC12933355 · PMID 41755979

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Among patients in the non-low-risk group, those treated with TKIs exhibited a numerically longer median survival of 41 months compared with 18.6 months in those treated with immunotherapy, although this difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.